Commonly, injections are administered once or twice weekly , but its essential to follow a personalized plan provided by a licensed clinician
Am J Physiol 276: H984992
Mounjaro (tirzepatide) is a once-weekly GLP-1 injectable approved for Type 2 diabetes and, at higher doses, for weight management in adults with obesity
To view a copy of this license, visit About this article Cite this article Arnold, D.P., Xu, Y
Triglyceride-glucose index correlate with telomere length in healthy adults from the National Health and Nutrition Examination Survey
When GI adverse effects remain severe or refractory despite these measures, temporary discontinuation of GLP-1 RA therapy or a structured drug holiday may be appropriate